Lazarus Benjamin, Kotwal Sradha, Gallagher Martin, Gray Nicholas A, Coggan Sarah, Rogers Kris, Talaulikar Girish, Polkinghorne Kevan R
The George Institute for Global Health, UNSW, Sydney, Australia.
Department of Medicine, Monash University, Clayton, Victoria, Australia.
Kidney Int Rep. 2023 Jul 27;8(10):1941-1950. doi: 10.1016/j.ekir.2023.07.013. eCollection 2023 Oct.
Effective strategies to prevent hemodialysis (HD) catheter dysfunction are lacking and there is wide variation in practice.
In this analysis of the REDUcing the burden of dialysis Catheter ComplicaTIOns: a national (REDUCCTION) stepped-wedge cluster randomized trial, encompassing 37 Australian nephrology services, 6361 participants, and 9872 catheters, we investigated whether the trial intervention, which promoted a suite of evidence-based practices for HD catheter insertion and management, reduced the incidence of catheter dysfunction, which is defined by catheter removal due to inadequate dialysis blood flow. We also analyzed outcomes among tunneled cuffed catheters and sources of event variability.
A total of 873 HD catheters were removed because of dysfunction over 1.12 million catheter days. The raw incidence was 0.91 events per 1000 catheter days during the baseline phase and 0.68 events per 1000 catheter days during the intervention phase. The service-wide incidence of catheter dysfunction was 33% lower during the intervention after adjustment for calendar time (incidence rate ratio = 0.67; 95% confidence interval [CI], 0.50-0.89; = 0.006). Results were consistent among tunneled cuffed catheters (adjusted incidence rate ratio = 0.68; 95% CI, 0.49-0.94), which accounted for 75% of catheters ( = 7403), 97.4% of catheter exposure time and 88.2% of events ( = 770). Among tunneled catheters that survived for 6 months (21.5% of tunneled catheters), between 2% and 5% of the unexplained variation in the number of catheter dysfunction events was attributable to service-level differences, and 18% to 36% was attributable to patient-level differences.
Multifaceted interventions that promote evidence-based catheter care may prevent dysfunction, and patient factors are an important source of variation in events.
缺乏有效的策略来预防血液透析(HD)导管功能障碍,并且实践中存在很大差异。
在这项“降低透析导管并发症负担:一项全国性(REDUCCTION)阶梯楔形整群随机试验”的分析中,该试验涵盖37个澳大利亚肾脏病服务机构、6361名参与者和9872根导管,我们调查了促进一系列基于证据的HD导管插入和管理实践的试验干预措施是否降低了导管功能障碍的发生率,导管功能障碍定义为因透析血流量不足而拔除导管。我们还分析了带隧道涤纶套导管的结局以及事件变异性的来源。
在超过112万导管日期间,共有873根HD导管因功能障碍被拔除。基线期的原始发生率为每1000导管日0.91次事件,干预期为每1000导管日0.68次事件。在对日历时间进行调整后,干预期间全服务范围内导管功能障碍的发生率降低了33%(发生率比值=0.67;95%置信区间[CI],0.50 - 0.89;P = 0.006)。带隧道涤纶套导管的结果一致(调整后的发生率比值=0.68;95%CI,0.49 - 0.94),这些导管占导管总数的75%(n = 7403)、导管暴露时间的97.4%和事件的88.2%(n = 770)。在存活6个月的隧道导管中(占隧道导管的21.5%),导管功能障碍事件数量中2%至5%的无法解释变异归因于服务水平差异,18%至36%归因于患者水平差异。
促进基于证据的导管护理的多方面干预措施可能预防功能障碍,并且患者因素是事件变异性的重要来源。